Free Trial

60,109 Shares in UnitedHealth Group Incorporated (NYSE:UNH) Bought by Raiffeisen Bank International AG

UnitedHealth Group logo with Medical background

Raiffeisen Bank International AG purchased a new stake in UnitedHealth Group Incorporated (NYSE:UNH - Free Report) in the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor purchased 60,109 shares of the healthcare conglomerate's stock, valued at approximately $30,523,000.

Other institutional investors and hedge funds have also recently bought and sold shares of the company. NewSquare Capital LLC bought a new stake in shares of UnitedHealth Group in the 4th quarter worth about $25,000. Marshall & Sterling Wealth Advisors Inc. acquired a new stake in shares of UnitedHealth Group in the fourth quarter valued at $26,000. Hurley Capital LLC bought a new stake in UnitedHealth Group during the 4th quarter worth about $28,000. AlphaMark Advisors LLC acquired a new position in shares of UnitedHealth Group during the fourth quarter worth approximately $30,000. Finally, Aster Capital Management DIFC Ltd bought a new position in UnitedHealth Group in the 4th quarter worth approximately $30,000. Institutional investors own 87.86% of the company's stock.

UnitedHealth Group Stock Performance

Shares of NYSE UNH opened at $308.35 on Thursday. The stock has a 50 day moving average of $478.83 and a 200-day moving average of $517.83. UnitedHealth Group Incorporated has a 12 month low of $284.25 and a 12 month high of $630.73. The company has a market capitalization of $279.72 billion, a P/E ratio of 19.89, a P/E/G ratio of 1.37 and a beta of 0.56. The company has a current ratio of 0.83, a quick ratio of 0.91 and a debt-to-equity ratio of 0.74.

UnitedHealth Group (NYSE:UNH - Get Free Report) last posted its earnings results on Thursday, April 17th. The healthcare conglomerate reported $7.20 EPS for the quarter, missing the consensus estimate of $7.29 by ($0.09). UnitedHealth Group had a net margin of 3.60% and a return on equity of 26.69%. The firm had revenue of $109.58 billion during the quarter, compared to analyst estimates of $111.56 billion. During the same period in the previous year, the company posted $6.91 EPS. As a group, equities research analysts predict that UnitedHealth Group Incorporated will post 29.54 EPS for the current year.

UnitedHealth Group Announces Dividend

The company also recently disclosed a quarterly dividend, which was paid on Tuesday, March 18th. Shareholders of record on Monday, March 10th were paid a dividend of $2.10 per share. The ex-dividend date of this dividend was Monday, March 10th. This represents a $8.40 dividend on an annualized basis and a yield of 2.72%. UnitedHealth Group's payout ratio is 35.18%.

Analyst Ratings Changes

Several research analysts have recently issued reports on the stock. JPMorgan Chase & Co. reduced their target price on shares of UnitedHealth Group from $652.00 to $525.00 and set an "overweight" rating on the stock in a research note on Thursday, April 24th. Morgan Stanley reduced their price target on UnitedHealth Group from $563.00 to $374.00 and set an "overweight" rating on the stock in a research report on Wednesday. Wells Fargo & Company reduced their target price on UnitedHealth Group from $677.00 to $351.00 and set an "overweight" rating on the stock in a report on Wednesday. HSBC reiterated a "hold" rating and set a $490.00 target price on shares of UnitedHealth Group in a report on Tuesday, April 22nd. Finally, Cantor Fitzgerald reiterated an "overweight" rating and issued a $700.00 price target on shares of UnitedHealth Group in a report on Friday, January 17th. Six research analysts have rated the stock with a hold rating, eighteen have given a buy rating and one has issued a strong buy rating to the stock. According to MarketBeat.com, UnitedHealth Group has a consensus rating of "Moderate Buy" and a consensus target price of $523.52.

Get Our Latest Research Report on UNH

UnitedHealth Group Company Profile

(Free Report)

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.

Read More

Institutional Ownership by Quarter for UnitedHealth Group (NYSE:UNH)

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in UnitedHealth Group Right Now?

Before you consider UnitedHealth Group, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and UnitedHealth Group wasn't on the list.

While UnitedHealth Group currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

7 Stocks to Buy And Hold Forever Cover

Enter your email address and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

7 Nuclear Stocks One Announcement Away from Exploding
3 AI ETFs for Steady Gains in 2025 (Without the Wild Volatility)
Goldman Sachs Warns of 20% Market Drop—Are They Right?

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines